Search

everythinglearnresearchcommunity

for

Search:↓

Bimatoprost is safe and effective for treating eyelash loss caused by chemotherapy.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Vitamin D3 may protect rat hair follicles from radiation damage.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Taking selenium supplements during chemotherapy may help reduce side effects and improve health markers in ovarian cancer patients.

The Wnt/β-catenin pathway helps tissue regeneration but can also cause fibrosis, and drugs that inhibit this pathway may aid in healing skin and heart tissues.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Chemotherapy-induced hair loss is a major concern, but various treatments show promise in preventing and reversing it.

Cannabis, cryotherapy, and scalp cooling can help improve the quality of life for chemotherapy patients.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Treat hair loss in postmenopausal women with diet, avoiding certain drugs, and using medications like minoxidil or finasteride.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Some cancer treatments cause different types of hair loss, but scalp cooling can help prevent it.

Topical mitotic blocking agents like colchicine can be dangerous and potentially fatal, and hair loss from rapid weight loss is due to low protein, not the speed of weight loss.

Newly made nicotinamide compounds could potentially treat cancer.